- Home
- >
- News & Insights
Perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin and docetaxel offers better overall survival than preoperative chemoradiotherapy for patients with locally advanced oesopahgeal adenocarcinoma, the ESOPEC trial investigators report. …more
Progression-free survival findings from two phase 3 clinical trials support the use of targeted therapies in combination with transarterial chemoembolisation for the treatment of patients with unresectable, nonmetastatic hepatocellular carcinoma. …more
Two-year interim findings from the EUROPA trial indicate that radiotherapy after surgery for low-risk early breast cancer may be better for preserving health-related quality of life for women aged 70 years and older than endocrine therapy. …more
Research suggests that an electrocardiography-based artificial intelligence risk estimator for hypertension may help to identify patients with an increased risk of developing hypertension and its related adverse outcomes. …more
All articles loaded
No more articles to load

Don’t fall behind!
Get the latest headlines – in your specialties of choice – delivered straight to your inbox.showcase
MEET THE SENIOR TEAM

Lynda Williams
medwireNews Deputy Bureau Chief